Histological assessment of paxgene tissue fixation and stabilization reagents

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Kap, Marcel ^a   Smedts, Frank ^a,f   Oosterhuis, Wolter ^a   Winther, Rosa ^b   Christensen, Nanna ^b   Reischauer, Bilge ^c,g   Viertler, Christian ^d   Groelz, Daniel ^e   Becker, Karl Friedrich ^c   Zatloukal, Kurt ^d   Langer, Rupert ^c   Slotta Huspenina, Julia ^c   Bodo, Koppany ^d   de Jong, Bas ^a   Oelmuller, Uwe ^e   Riegman, Peter ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b Dako   (Denmark)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e QIAGEN GMBH   (Germany)

^f REINIER DE GRAAF HOSPITAL   (Netherlands)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; REAGENT; TISSUE ANTIGEN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN; NUCLEIC ACID;

ANTIGEN DETECTION; ANTIGENICITY; ARTICLE; CELL DEGENERATION; CELL TYPE; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; ERYTHROCYTE LOSS; ERYTHROCYTE PARAMETERS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MOLECULAR PATHOLOGY; TISSUE FIXATION; TISSUE MICROARRAY; TISSUE PRESERVATION; TISSUE SECTION; TISSUE STRUCTURE; BREAST TUMOR; FEMALE; GENETICS; LABORATORY; METABOLISM; METHODOLOGY; PATHOLOGY; PROTEOMICS;

BREAST NEOPLASMS; FEMALE; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INDICATORS AND REAGENTS; LABORATORIES; NUCLEIC ACIDS; PARAFFIN EMBEDDING; PROTEOMICS; RECEPTOR, ERBB-2; TISSUE FIXATION;

EID: 81155150455     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027704     Document Type: Article

References (23)

1. Oosterhuis JW, Coebergh JW, van Veen EB, (2003) Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer 3 (1): 73-7.
2. Taylor CR, (2006) Standardization in immunohistochemistry: the role of antigen retrieval in molecular morphology. Biotechnic & Histochemistry 81 (1): 3-12.
3. Balgley BM, Guo T, Zhao K, Fang X, Tavassoli FA, et al. (2009) Evaluation of Archival Time On Shotgun Proteomics Of Formalin-Fixed and Paraffin-Embedded Tissues. J Proteome Res 8 (2): 917-925.
4. Gnanapragasam VJ, (2009) Unlocking the molecular archive: the emerging use of formalin-fixed paraffin-embedded tissue for biomarker research in urological cancer. BJU International 105: 274-278.
5. Kristensen LS, Wojdacz TK, Thestrup BB, Wiuf C, Hager H, et al. (2009) Quality assessment of DNA derived from up to 30 years old formalin-fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM. BMC Cancer 9: 453.
6. Hoefig KP, Thorns C, Roehle A, Kaehler C, Wesche KO, et al. (2008) Unlocking pathology archives for microRNA-profiling. Anticancer Res 28 (1A): 119-23.
7. Huang WY, Sheehy TM, Moore LE, Hsing AW, Purdue MP, (2010) Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 19 (4): 973-7.
8. Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, et al. (2007) Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol 211 (3): 370-8.
9. Preusser M, Elezi L, Hainfellner JA, (2008) Reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimens. Clin Neuropathol 27 (6): 388-90.
10. Bolt HM, Degen GH, Hengstler JG, (2010) The carcinogenicity debate on formaldehyde: How to derive safe exposure limits? Arch Toxicol 84: 421-422.
11. Bosetti C, McLaughlin JK, Tarone RE, Pira E, La Vecchia C, (2006) Formaldehyde and cancer risk: a quantitative review of cohort studies through. Annals of Oncology 19: 29-43, 2008.
12. Vollmer E, Galle J, Lang DS, Loeschke S, Schultz H, et al. (2006) The HOPE technique opens up a multitude of new possibilities in pathology. Romanian Journal of Morphology and Embryology 47 (1): 15-19.
13. Boon ME, Schmidt U, Cramer-Knijnenburg GI, van Krieken JH, (1992) Using Kryofix as alternative for formalin results in more optimal and standardized immunostaining of paraffin sections. Pathol Res Pract 188 (7): 832-5.
14. Marcon N, (2009) Glyoxal: a possible polyvalent substitute for formaldehyde in pathology? Ann Pathol 29 (6): 460-7.
15. Titford ME, Horenstein MG, (2005) Histomorphologic Assessment of Formalin Substitute Fixatives for Diagnostic Surgical Pathology. Arch Pathol Lab Med 129: 502-506.
16. Ergin B, Meding S, Langer R, Kap M, Viertier C, et al. (2010) Proteomic analysis of PAXgene-Fixed Tissues. J Proteome Res 1:9 (10): 5188-96.
17. Bancroft JD, Stevens A, (1990) Theory and Practice of Histological Techniques. Third Edition. Churchill Livingstone pp. 188, 140, 132, 165.
18. Denk H, Moll R, Weybora W, Lackinger E, Vennigerholz F, et al. (1987) Intermediate filaments and desmosomal plaque proteins in testicular seminomas and non-seminomatous germ cell tumours as revealed by immunohistochemistry. Virchows Arch A Pathol Anat Histopathol 410 (4): 295-307.
19. Matthews AW, (2008) Bad Cancer Tests Drawing Scrutiny. Wall Street Journal january 4: B1.
20. von Ahlfen S, Missel A, Bendrat K, Schlumpberger M, (2007) Determinants of RNA quality from FFPE samples. PLoS One Dec 5;2 (12): e1261.
21. Benchekroun M, DeGraw J, Gao J, Sun L, von Boguslawsky K, et al. (2004) Impact of fixative on recovery of mRNA from paraffin-embedded tissue. Diagn Mol Pathol 13 (2): 116-25.
22. Blum F, (1894) Notiz uber die Anwendung des Formaldehyds (Formol) als Hartungs- und Conservirungsmittel. Anat Anz 9: 229-231.
23. Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, et al. (2009) TRANSBIG Consortium.: The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat Jul;116 (2): 295-302.